Evidence map›Paper›PMID 35074807›Full record

ArticleBMJ open2022

Improving breast cancer outcomes for Aboriginal women: a mixed-methods study protocol.

Vita Christie, MacKenzie Rice, Jocelyn Dracakis, Deb Green, Janaki Amin, Karen Littlejohn, Christopher Pyke, Debbie McCowen, Kylie Gwynne

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vita ChristieFaculty of Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia vita.christie@sydney.edu.au.ORCID 0000-0003-3887-8305
MacKenzie RiceThe University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.
Jocelyn DracakisThe University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.
Deb GreenArmajun Aboriginal Health Service, Armidale, New South Wales, Australia.
Janaki AminFaculty of Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.ORCID 0000-0003-2161-9366
Karen LittlejohnFoundation for Breast Cancer Care, Sydney, New South Wales, Australia.
Christopher PykeFoundation for Breast Cancer Care, Sydney, New South Wales, Australia.
Debbie McCowenArmajun Aboriginal Health Service, Inverell, New South Wales, Australia.
Kylie GwynneFaculty of Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBreast cancer is the most commonly diagnosed cancer affecting Australian women, and the second highest cause of cancer death in Australian women. While the incidence of breast cancer is lower in Aboriginal women than non-Aboriginal women, the mortality rate for Aboriginal women is higher, with Aboriginal women 1.2 times more likely to die from the disease. In New South Wales, Aboriginal women are 69% more likely to die from their breast cancer than non-Aboriginal women.Co-design is a research method recognised to enhance collaboration between those doing the research and those impacted by the research; which when used with Aboriginal communities, ensures research and services are relevant, culturally competent and empowers communities as co-researchers. We report the development of a new protocol using co-design methods to improve breast cancer outcomes for Aboriginal women. METHODS AND ANALYSIS: Through a Community Mapping Project in 2018, we co-designed an iterative quantitative and qualitative study consisting of five phases. In Phase 1, we will establish a governance framework. In Phase 2, we will provide information to community members regarding the modified parts of the screening, diagnosis, treatment and follow-up processes and invite them to partake. In Phase 3, the research team will collect data on the outcomes of the modified processes and the outcomes for the women who have and have not participated. The data shall be analysed quantitatively and thematically in Phase 4 with Aboriginal community representatives and reported back to community. Lastly, in Phase 5, we evaluate the co-design process and adapt our protocol for use in partnership with other communities. ETHICS AND DISSEMINATION: This study has ethics approval of the Aboriginal Health and Medical Research Council ref:1525/19. The findings will be published in the literature, presented at conferences and short summaries will be issued via social media.

Indexed as

Breast NeoplasmsHealth Services, IndigenousAustraliaAustralian Aboriginal and Torres Strait Islander PeoplesFemaleHumansadult oncologybreast tumourshealth policypublic healthquality in health care

Identifiers

PMID35074807
PMCPMC8788241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.